Written by Admin | May 19, 2020
Bloomberg reports that the FDA is pairing up with the data analytics company Aetion to research COVID-19 complications and what types of medicines virus patients are taking, which could help researchers learn more about which treatments are most effective and for whom. The FDA is already using its internal drug monitoring system called Sentinel to learn more about COVID-19 responses nationwide.
Read More